Home | Published Research | Acceptability of a long‐acting injectable HIV prevention product among US and African women: Findings from a phase 2 clinical Trial (HPTN 076)

October 31, 2019

Acceptability of a long‐acting injectable HIV prevention product among US and African women: Findings from a phase 2 clinical Trial (HPTN 076)

Written By

Tolley EE, Li S, Zangeneh SZ, Atujuna M, Musara P, Justman J, Pathak S, Bekker LG, Swaminathan S, Stanton J, Farrior J